Opportunistic yeast pathogens: reservoirs, virulence mechanisms, and therapeutic strategies

Elizabeth J Polvi1, Xinliu Li, Teresa R O'Meara

  • 1Department of Molecular Genetics, University of Toronto, 1 King's College Circle, Medical Sciences Building, Room 4368, Toronto, ON, M5S 1A8, Canada.

Insights

Invasive fungal infections are rising in immunocompromised individuals. Combating antifungal drug resistance and improving diagnostics are crucial for better patient outcomes worldwide.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Immunology

Background:

  • Invasive fungal infections (IFIs) are a growing global health concern, particularly in immunocompromised patients.
  • Opportunistic fungal pathogens exploit weakened immune systems, leading to severe infections from commensal or environmental sources.
  • Fungal pathogens possess traits like host survival and morphological switching that contribute to disease.

Purpose of the Study:

  • To review the global burden of fungal infections.
  • To explore fungal pathogen reservoirs and pathogenic traits.
  • To address challenges in combating antifungal drug resistance and improving clinical outcomes.

Main Methods:

  • Literature review focusing on global fungal infection data.
  • Analysis of fungal pathogen characteristics and host genetic factors.
  • Examination of current diagnostic limitations and treatment strategies.

Main Results:

  • Increased incidence of IFIs linked to medical immunosuppression.
  • Identification of key virulence factors in opportunistic fungi.
  • Rising antifungal drug resistance poses a significant clinical challenge.

Conclusions:

  • Urgent need for improved diagnostic tools and novel therapeutic strategies.
  • Addressing antifungal resistance is critical for managing IFIs.
  • Enhanced understanding of host-pathogen interactions is essential for clinical advancement.

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
100
Bioreactor Controls-III01:22

Bioreactor Controls-III

Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
57
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
759
Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
2.1K
Infection01:20

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
14.8K
Colonisation of Pathogens01:25

Colonisation of Pathogens

Pathogen colonization of host tissues is a critical step in the development of infectious diseases. Various pathogenic microorganisms, including bacteria, fungi, viruses, and protozoa, have evolved complex strategies to attach to, invade, and persist within host environments. These mechanisms enable pathogens to establish infections, evade immune responses, and resist antimicrobial treatments.Attachment to Host CellsIn bacteria, colonization typically begins with adherence to host epithelial...
63